Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Hill Dermaceuticals
Hill Dermaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Dermotic
Fluocinolone
1988-02-03
2027-2030
Psoriasis
,
Atopic dermatitis
,
Pruritus
,
Inflammation
,
Facial dermatoses
,
Foot dermatoses
,
Hand dermatoses
,
Scalp dermatoses
,
Leg dermatoses
,
Acne vulgaris
,
Promyelocytic leukemia acute
,
Hyperpigmentation
,
Bacterial infections
,
Bacterial skin diseases
,
Escherichia coli infections
,
Hepatic encephalopathy
,
Neutropenia
,
Prostatitis
,
Fever
,
Urinary tract infections
,
Sinusitis
,
Typhoid fever
,
Diarrhea
,
Gonorrhea
,
Intraabdominal infections
,
Pseudomonas infections
,
Osteomyelitis
,
Campylobacter infections
,
Bacterial conjunctivitis
,
Staphylococcal infections
,
Infectious arthritis
,
Pyelonephritis
,
Proteus infections
,
Anthrax
,
Klebsiella infections
,
Otitis externa
,
Haemophilus infections
,
Protozoan infections
,
Cystitis
,
Dysentery
,
Bacteroides infections
Tolak
Fluorouracil
2015-09-18
Breast neoplasms
,
Pancreatic neoplasms
,
Stomach neoplasms
,
Head and neck neoplasms
,
Basal cell carcinoma
,
Colonic neoplasms
,
Rectal neoplasms
,
Keratosis
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use